Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial ; volume:21 ; number:1 ; day:10 ; month:4 ; year:2021 ; pages:1-8 ; date:12.2021
BMC infectious diseases ; 21, Heft 1 (10.4.2021), 1-8, 12.2021
- Urheber
-
Ranjbar, Keivan
Moghadami, Mohsen
Mirahmadizadeh, Alireza
Fallahi, Mohammad Javad
Khaloo, Vahid
Shahriarirad, Reza
Erfani, Amirhossein
Khodamoradi, Zohre
Gholampoor Saadi, Mohammad Hasan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-021-06045-3
- URN
-
urn:nbn:de:101:1-2021102818521168454153
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ranjbar, Keivan
- Moghadami, Mohsen
- Mirahmadizadeh, Alireza
- Fallahi, Mohammad Javad
- Khaloo, Vahid
- Shahriarirad, Reza
- Erfani, Amirhossein
- Khodamoradi, Zohre
- Gholampoor Saadi, Mohammad Hasan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Dexamethasone – A Corticosteroid Reduces Death in Severe COVID-19
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study
Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Ultrasound guided lavage with corticosteroid injection versus sham lavage with and without corticosteroid injection for calcific tendinopathy of shoulder: randomised double blinded multi-arm study
Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
A Synthetic Corticosteroid, Dexamethasone Regulates Generation of Soluble Form of Interleukin-6 Receptor of Human Lymphocytes, in vitro
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Dexamethasone – A Corticosteroid Reduces Death in Severe COVID-19
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study
Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Ultrasound guided lavage with corticosteroid injection versus sham lavage with and without corticosteroid injection for calcific tendinopathy of shoulder: randomised double blinded multi-arm study
Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
A Synthetic Corticosteroid, Dexamethasone Regulates Generation of Soluble Form of Interleukin-6 Receptor of Human Lymphocytes, in vitro
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Dexamethasone – A Corticosteroid Reduces Death in Severe COVID-19
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study
Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Ultrasound guided lavage with corticosteroid injection versus sham lavage with and without corticosteroid injection for calcific tendinopathy of shoulder: randomised double blinded multi-arm study
Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study